Schedule 2 to the Principal Order is amended as follows:

(a) by omitting item 2054 and substituting the following:

2054.	Fluorides for human use –
	(a) in preparations for ingestion containing 0.5mg or less of fluoride ion per dosage unit; or
	(b) in liquid preparations for topical use containing 1 000mg/kg or less of fluoride ion, in a container with a child-resistant closure –
	(i) for therapeutic use when compliant with the requirements of the Required Advisory Statements for Medicine Labels (September 2008) , except in preparations containing 220mg/kg or less of fluoride ion, in packs containing not more than 120mg total fluoride, when fitted with a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels ; or
	(ii) for non-therapeutic use when labelled with warnings to the following effect:
	(A) Do not swallow;
	(B) Do not use [this product/name of product] in children 6 years of age or less –
	except in preparations containing 220mg/kg or less of fluoride ion, in packs containing not more than 120mg total fluoride, when fitted with a child-resistant closure and labelled with warnings to the following effect:
	(A) Do not swallow;
	(B) Do not use [this product/name of product] in children 6 years of age or less –
	except in preparations containing 15mg/kg or less of fluoride ion or preparations for supply to registered dental professionals or by approval of an appropriate authority.

(b) by omitting item 2058 .